NETEASE INC-ADR
NTESNASDAQ🏆 #623 by market capEarnings Aug 20 · PreUS Equity
$566.92▲ $20.69 (+3.65%)
Simulated price1h—
24h▲ 3.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$12.35B
Mid Cap
📈Revenue Growth (YoY)
+6.6%
Slowing
📊Gross Margin
65.7%
High
💵FCF Margin
44.1%
Strong
⚖️P/S Ratio
4.9x
Fair
Otter Score
61
Fair
No chart data available for NTES.
Trading Snapshot
- Day Range
- $565.07 – $571.78
- 52-Week Range
- —
- Volume
- $4.89B
- Avg Volume
- $4.08B
- Shares Outstanding
- 3.20B
- Next Earnings
- Oct 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.51B
- Last Q Revenue
- $616M
- P/E Ratio
- 16.5
- P/S Ratio
- 4.9x
- EPS (TTM)
- —
- Dividend Yield
- 2.38%
Why Investors Own NTES
- ✓High-growth profile — revenue up +16.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 60% gross margin and 11% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$2.51B▲ +12.8% YoY
Gross Margin (TTM)
59.6%▲ +2.4% YoY
Operating Income (TTM)
$389M▲ +12.8% YoY
Free Cash Flow (TTM)
$279M▲ +12.8% YoY
About NETEASE INC-ADR
A company profile for NETEASE INC-ADR isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
61/100
Analyst Price Target
ⓘAverage Target
$740.87
▲ +30.7% Upside
High Target$909.22
Low Target$559.55
Based on 31 analysts
Latest News & Updates
🚀
Barron’s·2h ago
NETEASE INC-ADR tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift NTES price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
NETEASE INC-ADR announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.